
# EyeSha Annual Report 2024 2025 / 









We’re a dedicated team of health professionals committed to preventing child blindness. Our experts have decades of experience in child and baby eye health across diverse global communities, bringing expertise, empathy, and innovative solutions to areas where eye care is most urgently needed. Together, we aim to create transformative, lasting change—giving children a brighter future filled with endless opportunities. 


- **Registration history:** 04 January 2024 

- **Organisation type:** CIO 

- **Charity number:** 1206386 

- **Trustee(s):** 

   - ⚬ Dr Aeesha Malik 

   - ⚬ Dr Eslam Abdelhamid Elbaaly 

   - ⚬ Dr Naomi Wright 


- **Chief Executive:** Aeesha NJ Malik 

- **Address:** THE GRANARY, LAUGHTON ROAD RINGMER LEWES, BN8 5NQ 

- **Website: www.eyesha.org** 

1 






EYESHA Foundation is dedicated to preventing avoidable blindness and improving access to quality eye care for children and communities in lowand middle-income countries. 

## **Charitable Objects** 

For the public benefit, the objects of the foundation are specifically restricted to the following: 

- **1.The relief of sickness and the preservation of health** among people residing in low- and middle-income countries. 

- 2.To achieve this purpose by means of, but not exclusively: 

   - ⚬ Making **grants to organisations** that further the same charitable purposes. 

   - ⚬ **Providing or assisting in the provision of screening and treatment** for individuals suffering from eye diseases. 

   - ⚬ **Supporting community-based campaigns** to combat Neglected Tropical Diseases (NTDs), including mass drug administration, hygiene education, and clean water initiatives. 

## **Public Benefit Statement** 

The trustees confirm that they have had due regard to the Charity Commission’s guidance on public benefit when planning and delivering the charity’s activities. 

2 





## **Vision** 


Ending preventable childhood blindness, where every community has equitable access to quality, sustainable eye care. 

## **Mission** 

To strengthen neonatal and child eye health systems in low- and middleincome countries through innovation, capacity building, and research — ensuring that every child receives early detection, treatment, and care. 

## **Our Approach** 

EYESHA’s work is built on a locally-led, globally-supported model that promotes sustainability, equity, and ownership. 

The Foundation’s approach centres on four key pillars: 

- **Local Partnerships** – Collaborating with Ministries of Health, hospitals, and community organisations to align efforts with national priorities. 

- **Capacity Building** – Training and empowering healthcare and community workers to deliver quality eye care independently and sustainably. 

- **Innovation and Technology** – Using affordable tools such as telemedicine, mobile imaging, and AI-assisted diagnosis to expand reach and improve care quality. 

- **Evidence and Advocacy** – Generating research and data to inform policy and integrate eye health into broader child health systems. 

3 





Collaboration is at the heart of EYESHA’s work. The Foundation achieves its impact through strong partnerships that combine global expertise, regional leadership, and local implementation. 


## **Children’s Eye Foundation of AAPOS** 


The Children’s Eye Foundation of the American Association for Pediatric Ophthalmology and Strabismus (CEF of AAPOS) is one of EYESHA’s key strategic and funding partners. 

In collaboration with EYESHA, CEF co-established the Stop Infant Blindness in Africa ( **SIBA** ) initiative — a regional effort aimed at preventing vision loss in premature infants across the continent. 

## **COECSA** 


## **(College of Ophthalmology of Eastern, Central, and Southern Africa)** 

EYESHA works in close partnership with COECSA, the regional professional body responsible for advancing ophthalmic training and eye health across Eastern, Central, and Southern Africa. 

Through this collaboration, COECSA supports the coordination and implementation of programme activities, maintains sound financial accountability, and leads advocacy to strengthen eye health training and services in the region. 

## **National Partnerships** 

## **Kenya, Uganda, Nigeria, and Ethiopia** 

EYESHA’s success depends on strong collaboration with Ministries of Health, public hospitals, and professional societies in each country. 

4 





## **1.Newborn Eye Health Programme** 

## **Telemedicine Screening for Retinopathy of Prematurity (ROP)** 


## **Programme Overview** 

The Telemedicine Screening Programme for ROP addresses one of the fastest-growing causes of childhood blindness in sub-Saharan Africa. With improved neonatal survival, premature infants are increasingly at risk of ROP, yet screening and treatment services remain limited. 

EYESHA launched this initiative to build **sustainable, country-led systems** for the early detection and management of ROP in **Kenya and Uganda** , ensuring that no infant loses sight from a preventable cause. 

## **The programme’s main objectives are to:** 

- 1.Establish sustainable **ROP screening and treatment** infrastructure within major neonatal intensive care units (NICUs). 


- **2.Strengthen local capacity** through targeted training for healthcare professionals and technicians. 

- 3.Implement a **telemedicine-based screening model** to improve coverage and access. 

- **4.Conduct research** on ROP prevalence, risk factors, and treatment outcomes to improve clinical outcomes and guide national policy. 

5 






The Newborn Eye Health Programme operates in **Kenya and Uganda** , with a **hub-andspoke telemedicine model** linking central hospitals to peripheral sites. 

- **Kenya** : 5 hospitals across Nairobi and Kiambu counties. 

- **Uganda** : 4 hospitals across Mbale, Kampala, Masaka, and Nsambya. 

The programme targets **preterm and low-birth-weight infants** in neonatal units, aiming to integrate routine eye screening into standard newborn care across both countries. 


- **776+ preterm infants screened** (Kenya = 455; Uganda = 321). 

- **53+ infants treated** for sight-threatening ROP (38 in Kenya; 15 in Uganda). 

- **60+** healthcare professionals trained in neonatal eye imaging and telemedicine. 

- Two national **telemedicine hubs** established: 

   - ⚬ Kenyatta National Hospital (Kenya) 

   - ⚬ Masaka Regional Hospital (Uganda) 

- National ROP screening guidelines were drafted, and a National Working Group was formed in Uganda. 




SCREENING COVERAGE OF ELIGIBLE INFANTS 

6 






## **Kenya** 

The foundation phase successfully established a national telemedicine network for neonatal eye screening. 

Key milestones include: 

- **Infrastructure setup** in Kenyatta National, Mbagathi, Mama Lucy Kibaki, Pumwani Maternity, and Kiambu County Hospitals. 

- **Kenyatta National Hospital** designated as the **central hub** for image review, training, and coordination. 

- Formal **partnerships** signed between **COECSA** , **EYESHA** , and **SIBA** , outlining 

   - shared resources and responsibilities. 


The team visiting Kiambu County Newborn 

Unit 

## **Training (March–April 2025):** 

- Led by Dr. Shwetha Mangalesh (EYESHA) in collaboration with COECSA 

   - technicians. 

- Combined theoretical instruction, model-eye simulation, and live infant imaging 

   - using the **Forus 3nethra Neo® camera.** 

- **24 stakeholders** from Nairobi’s main hospitals attended the launch meeting. 

7 

6 






## **Kenya** 

- **Programme rollout (April 2025 onward):** 

   - ⚬ Tele-screening began at peripheral hospitals under the central hub model. 

   - ⚬ Monthly screenings **rose from 52 in April to 202 in July** , showing rapid adoption and staff proficiency. 

- **Ongoing mentorship:** Regular feedback meetings transitioned from weekly to monthly as local confidence grew. 



ROP tele-screening team in action at Kenyatta National Hospital 

## **Challenges:** 

Early challenges with image quality due to unfamiliar technology were addressed through continuous mentorship and quality feedback. Teams now perform screenings independently and report routinely. 

8 

6 






## **Uganda** 

In Uganda, the programme was launched under the “Hope and Vision” initiative at Mbale Regional Referral Hospital in **March 2025** , led by Dr. Kathy Burgoine, Dr. Iddi Ndyabawe, and Dr. Shwetha Mangalesh (EYESHA). 

The launch included theoretical and **hands-on training** for **13 healthcare** professionals, covering ROP screening, tele-screening workflows, and data management. Testimonies from mothers of preterm infants highlighted the lifechanging impact of early detection and care. 

## **From March 27 to April 1, 2025, EYESHA conducted a series of national workshops and stakeholder meetings to strengthen neonatal eye care and align national efforts:** 

- A Ministry of Health meeting resulted in the formation of a National ROP Steering Committee to oversee policy and guideline development. 

- Practical training sessions were held at Kawempe National Hospital, Mulago Medical College, and St. Francis Nsambya Hospital, training 26 additional professionals, including ophthalmology residents, neonatal nurses, and technicians. 

- Masaka Regional Referral Hospital was later designated as a telemedicine coordination hub, expanding coverage. 

- A virtual national meeting on April 1, 2025, gathered **28 experts** from across Uganda to consolidate lessons and plan the national rollout. 


9 6 






## **Uganda** 

## **Programme Rollout and Policy Development** 

- Telemedicine screening began at **Mbale Regional Referral Hospital** , using widefield imaging and indirect ophthalmoscopy to cover all eligible infants. 

- **Masaka Regional Hospital** prepared to act as a **secondary telemedicine hub** , extending screening and referral capacity. 

- **National ROP Guidelines** were drafted and are under review by the **Ministry of** 

   - **Health** , while a **National ROP Working Group** now coordinates implementation, 

quality assurance, and data reporting across sites. 




Trainees at the workshop getting hands-on experience and practice with the model eye with personalized feedback 

## **Challenges:** 

**Camera delivery delays** briefly slowed progress but were quickly resolved through coordination with **EYESHA** and **SIBA** . 

The **lack of official guidelines** initially limited standardisation; however, the draft national guidelines are now nearing approval. 

10 

6 







The **Child Eye Health Initiative** in Ethiopia builds on EYESHA’s regional experience in newborn and child vision care. Implemented in partnership with **Worldwide Orphans (WWO)** and the **Albert Einstein College of Medicine** , the project integrates **early vision screening** into preschool and primary healthcare settings to promote early detection and referral of eye conditions. 

## **Objectives** 

- Improve early detection of childhood eye diseases through school- and communitybased screening. 

- Train **teachers, nurses, and local health workers** to identify vision problems and refer children for care. 

- Strengthen **referral systems** linking schools and health facilities. 

- Raise community awareness on the importance of early eye screening. 

## **Key Highlights** 


- Conducted a **Training of Trainers (ToT)** workshop in Addis Ababa for **70 participants** , including preschool educators and health workers. 

- Developed Ethiopia-specific training modules and screening materials, adapted from EYESHA’s regional curriculum. 

- Provided **screening kits** and educational tools to five preschools and two hospitals, and **screened nearly 800 children** . 

- Formed partnerships with the Ministries of Health and Education to integrate child eye screening into school health programmes. 

11 

6 







EYESHA co-organised a **Regional ROP Workshop** during the **12th COECSA Annual Scientific Congress** held on 19 August 2025 in Addis Ababa, Ethiopia. 

- Jointly hosted with **SIBA** , the **Children’s Eye Foundation** , and **IPOSC,** the event gathered **46 delegates** from **eight** Sub-Saharan countries and global ROP experts to strengthen collaboration in neonatal eye health. 

## **Objectives** 

- Review progress and challenges in ROP care across the region. 

- Strengthen inter-country collaboration and create a unified action plan. 

- Explore innovations such as telemedicine, AI, and virtual reality (VR) to expand ROP screening and training. 

## **Key Highlights** 



- Country presentations shared experiences in screening, treatment, and policy development. 

- The success of telemedicine-based ROP screening in Kenya and Uganda demonstrated a scalable regional model. 

- Discussions highlighted the need for national ROP guidelines, data registries, and trained multidisciplinary teams. 

- Expert sessions showcased advances in telemedicine networks and VR tools for ophthalmic education in low-resource settings. 

1 6 2 







During this reporting year, EYESHA advanced neonatal and child eye health **across East Africa** through coordinated implementation, training, and regional collaboration. The Foundation: 

- Expanded t **elemedicine-based screening and treatment** for newborns and children across **Kenya, Uganda, and Ethiopia** . 

- Strengthened **national and regional systems** , contributing to Uganda’s **National ROP Guidelines** and a **Regional ROP Action Plan** through COECSA. 

- Built a **network of trained** healthcare professionals, teachers, and technicians now equipped to deliver early screening and referral. 

- Demonstrated a **scalable model for locally-led, globally-supported** eye care in low-resource settings. 


Delegates at the COECSA Regional ROP Workshop (Addis Ababa, August 2025) 

- Fostered cross-sector partnerships with Ministries of Health and Education to integrate eye health into national programmes. 

- Jointly hosted with SIBA, the Children’s Eye Foundation, and IPOSC, the event gathered 46 delegates from eight Sub-Saharan countries and global ROP experts to strengthen collaboration in neonatal eye health. 

1 6 3 







Looking ahead, EYESHA will build on these achievements by: 

- **Scaling up** telemedicine screening to **new hospitals** in Kenya, Uganda, and additional countries in Southern Africa. 

- Supporting the **implementation of national ROP guidelines** in Uganda and developing similar frameworks in Kenya and Ethiopia. 

- Launching **pilot projects in Tanzania and Zimbabwe/Zambia** based on the COECSA regional roadmap. 

- Expanding **training partnerships** with COECSA to reach more clinicians, nurses, and technicians across the region. 

- **Integrating AI-assisted imaging and virtual reality (VR)** training tools to improve diagnostic accuracy and medical education. 



- Continuing **operational and clinical research** to enhance service quality, followup, and long-term outcomes. 

- Strengthening **advocacy and resource mobilisation** to embed newborn and child eye health into national health strategies and budgets. 

14 

6 







EYESHA continues to expand its reach through new proposals and partnerships aimed at strengthening neonatal and child eye health across additional countries. These initiatives are designed to build on the Foundation’s ongoing work in East Africa and support long-term regional integration. 

## **Proposals in Development or Under Review:** 

- **Egypt** – Introduce community-based vision screening and early detection services in collaboration with national partners, focusing on underserved communities. 

- **Palestine** – Developing a newborn eye health programme to establish ROP screening and treatment services within neonatal units. 

- **Pakistan** – Pilot telemedicine screening for ROP and strengthen referral systems to improve access to specialised care. 

- **Tanzania** – Designing a community health worker (CHW) model to support early identification and referral of childhood eye diseases. 

## **Major Grant Proposals** 

- **Velux Foundation** – ROPAI (Retinopathy of Prematurity Artificial Intelligence Initiative): proposal to integrate AI-assisted image analysis into neonatal telemedicine to enhance diagnosis and workflow efficiency. 

- **Wellcome Trust** – ROP-AI Africa Model: Research collaboration to develop the first AI model for ROP detection in Africa, adapted to local populations and integrated within EYESHA’s telemedicine framework. 

1 6 5 






EYESHA Foundation is a **Charitable Incorporated Organisation (CIO)** registered in England and Wales under **charity number 1206386** . The Foundation is governed by a **Board of Trustees** that provides strategic oversight, ensures compliance with charity regulations, and guides the overall direction of the organisation. 

The Board delegates day-to-day management to the **Executive Team** , which oversees programme implementation, partner coordination, and financial management. Regular meetings between trustees and management ensure alignment with the Foundation’s objectives and accountability to donors, partners, and beneficiaries. 

EYESHA’s governance framework emphasises **transparency,** 

**collaboration, and shared responsibility** . Decisions are guided by the Foundation’s constitution and are informed by data, evidence, and continuous feedback from partners in the field. 

To ensure programme quality and integrity, EYESHA follows key governance principles: 

- **Accountability** : Clear roles and regular reporting mechanisms across all projects. 

- **Transparency** : Open communication with partners and stakeholders on progress and challenges. 

- **Ethical standards** : Compliance with UK Charity Commission guidelines and safeguarding policies. 

- **Partnership governance** : Collaboration with Ministries of Health, COECSA, and other partners to align programme priorities with national and regional strategies. 


1 

6 





Project funds supporting activities in Kenya and Uganda were **provided by the Children’s Eye Foundation of AAPOS (CEF)** and **transferred** through Stop Infant Blindness in Africa **(SIBA) directly to local partners** to support implementation on the ground. 

.. 

EYESHA manages these funds in coordination with national partners, ensuring all expenditure aligns with donor requirements and project objectives. 

During this reporting period, CEF’s support — channelled through SIBA — enabled the **continuation and expansion of the Newborn Eye Health Programme.** 

The funds covered training, equipment procurement, telemedicine operations, and policy development activities. 

## **Country Expenditure Summary (2024-2025)** 

## **Kenya – USD 98,695** 

Funds supported the establishment of a telemedicine screening network, including equipment procurement, staff training across five hospitals, and operational costs related to screening and data management. 

## **Uganda – USD 25,950** 

Funding covered national training workshops, development of ROP guidelines and data systems, and support for screening and coordination at the hospital level. 

## **Pending Disbursement – USD 38,000** 

Additional funds are pending for release at the end of 2025 to support equipment procurement in Uganda. 

## **Financial Accountability** 

EYESHA maintains clear reporting lines between its country teams, partners, and SIBA. All financial activities are monitored quarterly to ensure alignment with project objectives, proper documentation, and compliance with the Charity Commission’s financial standards. 

Regular reviews are conducted to track spending efficiency and value for money across all programmes. 

17 





Active Programmes Pipeline Proposal 



Across these countries, EYESHA works hand in hand with local partners to protect the sight of newborns and children. 

Each dot on this map represents a shared effort, a growing partnership, and a child whose future is a little brighter. 

**Thank you for being part of this journey.** 


www.eyesha.org +44(0)7787598237 


1 

8 




|**Charity NEYE SHA FOUNDATION**||**1206386**||
|---|---|---|---|
|**Receipts andpayments accounts**|||**CC16a**|
|04/01/2024<br>**For the period**<br>**from**|**To**|31/03/2025||



|**Section A Receipts and payments**|**Section A Receipts and payments**||||||
|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**28 906**<br>**500**<br>**7 593**<br>**-**<br>**-**<br>**36 999**<br>**-**<br>**-**<br>**-**<br> **36 999**<br>**2 659**<br>**288**<br>**500**<br>**7**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **3 454**<br>**-**<br>**-**<br> **-**<br>**3 454**<br>**33 545**<br>**-**<br>**-**<br>**33 545**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**28 906**<br>**500**<br>**7 593**<br>**-**<br>**-**<br>**36 999**<br>**-**<br>**-**<br>**-**<br>**36 999**<br>**2 659**<br>**288**<br>**500**<br>**7**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**3 454**<br>**-**<br>**-**<br>**-**<br>**3 454**<br>**33 545**||**Last year**<br>**to the nearest £**|
|US NGO(Worldwide Orphans)|**28 906**|||||**-**|
|Corporate donation|**500**|||||**-**|
|Individual donation|**7 593**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**36 999**|||||**-**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_ **<br>**A3 Payments**|||||||
|||||||**-**|
||||||||
|Travel expense|**2 659**|||||**-**|
|Equipmentpurchase|**288**|||||**-**|
|Project Management cost|**500**|||||**-**|
|Others|**7**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**3 454**|||||**-**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**-**|
||||||||
||**33 545**|**-**|**-**|**33 545**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**33 545**|**-**|**-**|**33 545**||**-**|



CCXX R1 accounts (SS) 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>Cash at Bank current account<br>Cash at Bank Saving Account<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>SIGN|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**31 545**<br>**-**<br>**2 000**<br>**-**<br>**-**<br>**-**<br>**33 545**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Aeesha Malik|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||SIGN|Aeesha Malik|23-Jan-26|
|||||



CCXX R2 accounts (SS) 

2 



Independent Examlnerfs Report to theTrustees of EYE SHA FOUNDATION
I report to the Iwstees on my examination of the accounts of the EYE SHA FOUNDATION for
the year ended 31 March 2025.
Re8ponslbliities and Ba818 of Report
As the charity trustees of the TNSL you are responsible for the preparation of the accounts in
accordance with the requirements ol the Charities Act 20111'the ACY).
I report in respect of my examinati￿ of the Trusvs accounts canied out under section 145 of
the 2011 Act and in carrying out my examination I have fdiowed all the applicable Directions
ven by the Charity Commission under section 145{5}{b) of the ACL
Independent Examlnerfs Ststsmont
I have completed myexamination. I confimithat no m8teri8lmatters have cometo my attention
in connection wrth the examination ts'ng me cause to believe that in any matsrial reS￿ct
accounting records were not kept in respect of the Trust as required by section 130 of
the Act; or
2. the accounts do not accord with those records.
I have no concems and have come across no other matters in Connection with the examination
to which attention should b8 drawn in this report in ordw to enable a proper understanding of
the accounts to be re8ched.
signed:
Namo: Atta Ul Haque (Fellow member ofACCAI
Addrn88: 35 Lambs Farm Road. RH12 4DB
Date: 23 January 2026